Croda stock rallies as investors digest fresh earnings
Published on 08/20/2026 at 20:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Croda International Plc (ISIN GB00BJFFLV09) stock has delivered a gain of 20.4% from the start of 2026 to trading on August 20, 2026, as the London-listed specialty chemicals group benefits from renewed interest in quality materials names.
According to recent stock analysis CRDA shares are now quoted at GBX 3,246, up from GBX 2,695 at the beginning of the year, putting the year-to-date rise at just over one fifth as of August 20, 2026.
Croda stock extends 2026 recovery
Fresh market data shows Croda stock changing hands at GBX 3,244 in London trading, with the latest quote recorded on August 20, 2026, and indicating a daily move of -0.80% at that snapshot compared with the prior close.
The same market overview highlights that Croda stock is modestly below an indicated average analyst price target of GBX 3,390, with target estimates spanning from GBX 3,200 at the low end to GBX 3,600 at the high end as of August 20, 2026, implying scope for incremental upside from current levels if forecasts prove accurate.
Sector performance tables for the UK equity market dated August 19, 2026, show that Croda International closed that session at 3,270.0 pence, ranking among the leaders in the UK 100 with a single-session gain of 5.3%, a move that underlines how quickly sentiment can swing when investors reprice earnings resilience.
Momentum backed by recent earnings
Equity research compiled on August 20, 2026, notes that Croda International most recently reported quarterly earnings on July 28, 2026, giving investors an updated view on profit trends in its core specialty chemicals businesses and helping to set expectations for the remainder of the year.
In that release the company reported earnings per share of $72.20 for the latest quarter, a figure that investors can compare against consensus and prior-period performance when assessing whether the latest rally in Croda stock is justified by fundamentals.
Recent data from the same source shows that Croda International generated a trailing twelve-month return on equity of 3.65% alongside a net margin of 4.61%, figures that frame the profitability backdrop behind the stock's 20.4% year-to-date advance and help explain why the market remains attentive to any sign of margin improvement.
The price-target overview indicates a moderate buy consensus rating for Croda stock, with the average objective of GBX 3,390 standing 4.4% above the latest GBX 3,246 share price as of August 20, 2026, quantifying the gap between market price and the aggregated analyst view.
Personal care and crop care portfolio
Croda International generates much of its revenue from high-value specialty ingredients used in personal care, life sciences, and performance technologies, selling into segments such as skin care formulations, crop protection, and polymer additives where customers typically value performance and reliability over volume commodity pricing.
Croda stock and trading snapshot
Based on the latest comprehensive stock overview as of August 20, 2026, Croda International is listed on the London Stock Exchange under the ticker CRDA, with a highlighted latest price of GBX 3,244 and a documented move from GBX 2,695 at the beginning of 2026, giving investors a clear view of the stock's trajectory during the current year.
Read more
Further details on Croda stock performance, earnings dates, and segment trends can be found on the company website and leading market-data portals.
Fact box
Company: Croda International Plc
ISIN: GB00BJFFLV09
Ticker: CRDA
Exchange: London Stock Exchange (LSE)
